Ticagrelor – toward more efficient platelet inhibition and beyond

Novel antiplatelet drugs, including ticagrelor, are being successively introduced into the therapy of atherothrombotic conditions due to their superiority over a standard combination of clopidogrel with acetylsalicylic acid in patients with acute coronary syndromes (ACS). A P2Y12 receptor antagonist...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Ther Clin Risk Manag
Asıl Yazarlar: Kubisa, Michał J, Jezewski, Mateusz P, Gasecka, Aleksandra, Siller-Matula, Jolanta M, Postuła, Marek
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove Medical Press 2018
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5775739/
https://ncbi.nlm.nih.gov/pubmed/29398917
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S152369
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller